CervoMed (NASDAQ:CRVO) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.66) by 15.15 percent. This is a 36.59 percent decrease over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $1.92 million which beat the analyst consensus estimate of $1.72 million by 11.35 percent. This is a 18.30 percent decrease over sales of $2.35 million the same period last year.